Scripps Research Translational Institute and NVIDIA enter a new partnership
With the aim to make bespoke medicine accessible worldwide, Scripps Research Translational Institute has focused on utilising tools of genomics and digital medicine and enhancing this through the use of exceptional technologies.
Becoming one of the largest independent, not-for-profit research organisations, the company has recently partnered with AI specialist NVIDIA to harness deep learning tools and methods to process and analyse genomic and digital medical sensor data.
By accelerating the application of artificial intelligence (AI) for disease prevention, health promotion and the streamlining of biomedical research efforts. Scripps and NVIDIA will focus on advancing the use of deep learning, a subset of AI that is poised to play a key role in improving clinical outcomes and reducing healthcare costs, the company has stated.
Eric Topol, MD, founder and director of Scripps Research Translational Institute and professor at Scripps Research.
“AI has tremendous promise to transform the future of medicine,” says Eric Topol, MD, founder and director of Scripps Research Translational Institute and professor.
- Johnson & Johnson looks to acquire Ci:z Holdings Co. Ltd for up to $2.05bn
- Bain Capital and Pfizer launch a new biopharma company
- New report shows how US hospitals could save over $25bn across their supply chains
“With NVIDIA, we aim to establish a centre of excellence for artificial intelligence in genomics and digital sensors, with the ultimate goal of developing best practices, tools and AI infrastructure for broader adoption and application by the biomedical research community.”
“AI is already transforming healthcare by using electronic health records and medical imaging to better diagnose and treat disease,” added Kimberly Powell, vice president of healthcare at NVIDIA. “Our collaboration with Scripps expands these opportunities by tapping into the rapid accessibility of genomic and digital wearable data, and furthers the quest to better predict and prevent disease.”
The move follows on from companies such as Apple, who have stated that the use of AI will help to enhance patients’ quality of life, give greater control back to patients regarding their healthcare needs and lower healthcare costs. Its new FDA-cleared Apple Watch ECG is one of the many health technologies set to revolutionise the market.
Through the partnership, similarly to Apple, Nvidia and Scripps will initially explore the use of AI to support those with atrial fibrillation and ways in which to deliver positive patient outcomes at each opportunity and boosting clinical efficiency through the use of enhanced health data.
Solent NHS launches UK's first sexual health self-service
Solent NHS Trust in the south of England has become the first in the UK to launch an integrated sexual health self-service system.
The national health service trust has launched a new Personal Health Record (PHR) that will enable patients to book and amend appointments online. This will allow clinicians to triage patients digitally, saving them time. If patients miss appointments then staff are alerted via simple push notifications.
Once it's fully implemented, Solent will be able to use the system for patients to easily access to repeat contraception, postal testing kits, results and prescriptions. PHR will also be used to anonymously notify partners who could be at risk of a sexually transmitted infection.
The PHR has been designed by healthcare IT provider Inform Health. Solent hopes the system will alleviate pressure on clinics that are currently reliant on traditional methods of booking appointments via the telephone. It will also provide holistic visibility of patient data, and allow patients to self-manage their sexual health by registering on a secure website and creating their own patient record.
PHR will further support Solent’s Sexual Health Services through the creation of joined-up, electronic patient records – a key benefit according to Ynez Symonds, Solent’s Sexual Health Services’ Head of Quality and Professions: “Our patients are at the heart of everything we do, so making their lives easier and being able to drill down to see what’s happening with patients in our area, so we can effectively target services, is really important" she said.
"We previously used a system that required patients to input the same demographic information every time they needed to request a testing kit or access condoms online. We know from patient feedback that for some this was a barrier to accessing services.
"Additionally, our previous system didn’t integrate with our Inform EPR (electronic patient record), used in clinics. This meant there was no easy way to see what patients were requesting and when they were returning kits, so it was near enough impossible to obtain a clear picture, assess trends and effectively tailor our future provision."
Symonds adds that the PHR system will also help them to reduce the risks of COVID-19 infection. "Like all NHS providers, we’re focused on resetting our services. We need to continue to adapt to minimise the risks of COVID-19 transmission, so PHR remains a top priority for us. I see it marking a real turning point for how patients access services and take greater control of their sexual health and wellbeing. I also think PHR will play an integral role in helping us to better target health promotion through quality data delivered through system integration.”